We’ve Got Your Back®

Claim My Business
Security Type
Non-Voting Equity
Technology, Healthcare & Medical
Min Investment
Offering Date
October 08, 2022
Expected Close Date
January 31, 2023
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Company Description

At FloSpine, we consider ourselves to be a leading medical device company applying new technology and design concepts to solve medical problems for the human spinal column. We believe our new, innovative, high-margin and cost-effective medical device spinal implants have the potential to disrupt the spinal implant market. With 6 US patents, 4 Patent Applications (2 International) and 3 FDA 510(k) clearance, we are in the market with our existing FDA-cleared product lines, and in prototyping stages for the development of new products, including KeyLift™.
FloSpine is registered as a Medical Device Manufacturer with the Food and Drug Administration (FDA).


Select this bonus

$298+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

Select this bonus

Super Early Bird Bonus – Friends and Family
Invest within the first 5 days and receive 10% bonus shares.





Select this bonus

$10,000+ Investment
Tier 1
Invest $10,000 and receive 4% bonus shares.

Select this bonus

$25,000+ Investment
Tier 2
Invest $25,000 and receive 7% bonus shares.

Select this bonus

$50,000+ Investment
Tier 3
Invest $50,000 and receive 10% bonus shares + a 30-minute zoom with our CEO.

Key Deal Facts

FloSpine currently offers and is developing new spinal fusion implants and instrumentation that, in our view, will allow surgeons to address 90% of patient needs. The orthopedic implant industry is characterized by very high gross profit margins and is currently the third highest in healthcare industry behind large pharmaceutical and biotech companies. FloSpine's Gross Margins on its products are at 70-80%.

The US is the biggest market for spinal implants, estimated $7.0 billion in 2016 and is expected to reach $12.2 billion by 2024, with 5% CAGR (source)

FloSpine’s leadership has over 40 years of spine and orthopedic experience. Peter Harris, President and CEO has worked for very successful start-up companies, including K2M which sold to Stryker for $1.4 B in 2018.

Management Team / Advisory Board Bios

Waldi Harris

Director of Administration and Corporate Secretary

As Co-Founder, Waldi contributes 30+ years of experience in Nursing, Education, HR & Payroll functions (50-250 weekly contractors); leading Administrative, QA & Inspection teams. 
Recently as a RN at Boca Raton Regional Hospital, she assisted with customizing & teaching medical staff the Cerner HER system for the Labor & Delivery, Postpartum, Newborn Nursery, and Neonatal ICU departments.
As top AE supporting AEG, Merck, J&J, & Qualcomm she was a talent scout of Executives, Finance and IT professionals. Waldi opened multiple employment branches & onsite offices; and over 100 franchises for owners of health equipment/salons.
Waldi’s primary function is managing FloSpine LLC, which is the operational side and is 100% owned by FloSpine Holdings Inc. Waldi contributes a couple of hours managing FloSpine Holdings Inc and approximately 50 hours/week working for FloSpine LLC.

James Spitler

Vice President of Research and Development

Mr. Spitler has more than 20 years of orthopedic experience in spine, total knee, shoulder and hip specializations. He has worked for Sulzer Medical, Arthrex, Medtronic, C.R. Bard, IMDS and brings start-up experience from IST with Texas Back Institute. Mr. Spitler owns more than 14 patents in spinal technology and has launched many successful products. He has a BS in Mechanical Engineering from Texas A&M University.

Tom Fellman

Director of Sales

Mr. Fellman is a veteran of the United States Navy. After receiving an honorable discharge he attended and graduated from the University of South Florida in Tampa, FL. After graduation Tom worked with several pharmaceutical companies. This exposure led him to opening up his own distributorship. 
Tom joined the Amendia team and within a few years he and his team worked their way up to be one of the largest distributors of spinal products in the US. Tom enjoys working with surgeons, listening to their obstacles and prides himself on providing solutions. 

Dr John Afshar

Chief Medical Officer

Dr. John Afshar is a board certified fellowship trained neurosurgeon specializing in minimally invasive surgery of the spine and the brain. He received both his undergraduate and medical degree from Georgetown University in Washington, DC. He completed his residency in neurologic surgery at the Georgetown University Medical Center in Washington, DC. During his residency he further received specialized training at the Armed Forces Institute of Pathology and Children’s National Medical Center in Washington, DC as well. He then underwent a research fellowship in brain tumors and cerebrovascular disease at the world renown National Institutes of Heath in Bethesda, Maryland where he published several scientific articles. He obtained national recognition for his research by receiving the Galbraith award from the Congress of Neurologic Surgeons. He further performed a spinal fellowship at Tampa General Hospital/University of South Florida in Tampa, Florida. He is a Diplomate of the prestigious American Board of Neurologic Surgery. He is also a member of the Congress of Neurologic Surgeons and the North American Spine Society. 
From his extensive experience at the Georgetown University Medical Center Dr. Afshar’s approach to his patients is based on the concept of “cura personalis” which translates as “ the care of the whole person “. With this compassionate guiding principle and evidence based medicine he will optimize both the conservative and surgical treatment outcomes of all his patients.

Dr Chen-Lun Soo

Medical Consultant

Dr. Cheng-Lun Soo, MD is a orthopedic spine specialist in Oklahoma City, OK. Dr. Cheng Lun Soo graduated from University of Kentucky College of Medicine in 1993 and completed his residency at Baylor College Of Medicine. He currently practices at One Core Health and is affiliated with Great Plains Regional Medical Center. Dr. Soo is board certified in Orthopedic Surgery.

Dr. Louis Raso

Medical Consultant

Board-certified in both pain management and anesthesiology, Louis J. Raso, MD, PA, is extensively trained in a wide range of services to relieve chronic pain and improve the quality of his patients’ lives. At his practice in Jupiter, Florida, Dr. Raso specializes in treating persistent pain that isn’t treatable with other therapies and focuses on identifying the root cause of his patients’ pain.
Dr. Raso is certified by the American Board of Anesthesiology and stays active in pain management research and technology. In addition to his clinic work, Dr. Raso authors articles on pain management techniques for medical journals and book chapters, and he lectures on the subject around the country and throughout Europe. 
After earning his medical degree from Rutgers New Jersey Medical School in Newark, New Jersey, Dr. Raso went on to complete both his training in anesthesiology and a fellowship in pain management at Thomas Jefferson University in Philadelphia. He remains actively involved in educating other physicians about spinal cord stimulation technology and research.

Dr Anup Gangavalli

Medical Consultant

Dr. Anup Gangavalli is an orthopedic surgeon specializing in minimally invasive and reconstructive spine surgery practicing at St Mary's Hospital in Richmond, VA
Dr. Gangavalli received his Medical Degree at Stony Brook University in New York where he obtained a BS in Neuroscience with Dual Honors in Research and a Minor in Chemistry. 
Dr. Gangavalli attended the Orthopedic Surgery Residency program at St. Luke’s University Hospital & Health Network in Bethlehem, PA and he completed his fellowship training in Spine Surgery at the Cleveland Clinic in Cleveland, OH. 
Dr. Gangavalli has gained ample exposure to a wide range of spinal pathologies and an extensive training in the diagnosis and management of adult spinal disorders including degenerative cervical, thoracic and lumbar disease, spinal deformity, intradural and extradural spinal tumors, spinal trauma, spinal infections, congenital spinal abnormalities, and complex reconstruction/revision cervical and lumbar pathology.
Amount Raised : $114,177
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

Non-voting stock is stock that provides the shareholder very little or no vote on corporate matters.

Research Reports

No reports have been submitted

Become a Reporter